Department of Cardiothoracic Surgery Weill Cornell Medicine New York City NY.
Nuffield Department of Surgical Sciences University of Oxford United Kingdom.
J Am Heart Assoc. 2019 Dec 3;8(23):e014638. doi: 10.1161/JAHA.119.014638. Epub 2019 Nov 22.
Background The ART (Arterial Revascularization Trial) showed no difference in survival at 10 years between patients assigned to the single versus bilateral internal thoracic artery grafting strategies. This finding is in contrast with the results of most observational studies, where the use of 2 internal thoracic arteries has been associated with improved survival. Methods and Results We selected propensity-matched studies from the most comprehensive observational meta-analysis on the long-term outcomes of patients receiving 1 versus 2 internal thoracic arteries. Individual participant survival data from each study and the ART were reconstructed using an iterative algorithm that was applied to solve the Kaplan-Meier equations. The reconstructed individual participant survival data were aggregated to obtain combined survival curves and Cox regression hazard ratios with 95% CIs. Individual participant survival data were obtained from 14 matched observational studies (24 123 patients) and the ART. The 10-year survival of the control group of ART was significantly higher than that of the matched observational studies (hazard ratio, 0.86; 95% CI, 0.80-0.93). The 10-year survival of the experimental group of ART was significantly lower than that of the bilateral internal thoracic artery group of the observational studies (hazard ratio, 1.11; 95% CI, 1.03-1.20). Conclusions Both the improved outcome of the control arm and the lower beneficial effect of the intervention had played a role in the difference between observational evidence and ART.
ART(动脉再血管化试验)显示,在 10 年的随访中,接受单侧与双侧内乳动脉搭桥策略的患者之间的生存率没有差异。这一发现与大多数观察性研究的结果形成对比,在这些研究中,使用两条内乳动脉与生存率的提高相关。
我们从关于接受 1 条或 2 条内乳动脉患者长期结局的最全面的观察性荟萃分析中选择了倾向评分匹配的研究。使用迭代算法重建来自每个研究和 ART 的个体参与者生存数据,该算法应用于解决 Kaplan-Meier 方程。将重建的个体参与者生存数据进行汇总,以获得合并的生存曲线和 Cox 回归风险比(95%CI)。从 14 项匹配的观察性研究(24123 名患者)和 ART 中获得个体参与者生存数据。ART 对照组的 10 年生存率明显高于匹配的观察性研究(风险比,0.86;95%CI,0.80-0.93)。ART 实验组的 10 年生存率明显低于观察性研究中的双侧内乳动脉组(风险比,1.11;95%CI,1.03-1.20)。
观察性证据与 ART 之间的差异是由对照组结果的改善和干预措施的有益效果降低共同作用的结果。